Reimbursement of telemedicine and digital care in the Netherlands


Aug 2020

Digitization is playing an increasingly important role in the organization of healthcare. Under digital care, Dutch Healthcare Authority (NZa) considers the application of both digital information and digital communication to support and / or improve healthcare. The same definition is applicable to the term e-health implemented by the Centre of expertise for standardization and eHealth (Nictiz).

The following classification of digital care was developed by the Council for Public Health and Society:

  • E-care: e-diagnosis, e-consultations, e-care such as monitoring, e-prevention intervention at high risk in an individual;
  • E-support: e-access to patient records, e-management such as making appointments online;
  • E-public health: e-health education, e-prevention such as detecting certain risk groups.

Only digital care that meets the so-called 'package criteria' may be declared by care providers under the Health Insurance Act (Zvw) and Long-term Care Act (Wlz). The main criterion is that care must be safe and proven to be effective. The Zvw describes which medical devices (such as e-health technology) are eligible for reimbursement from the basic package. Certain medical aids are part of the specialist medical care and are charged to the hospital (via DRG). Others fall under medical device care and are reimbursed separately by the health insurer.

In 2021, the 'Telephone Consultation' performance will be replaced by the new ‘Triage consultation' service: a distinction will be made between the first contact (the triage) and the possible follow-up (consultation or visit). The consultation can take place at the GP office, the patient's home, or in digital form (via video call, for example). The existing 'Telephone consultation' performance may be used for this purpose up to December 31, 2020. Since 2021, the new 'Triage consultation' performance (in which the method of delivery no longer matters) can be declared by the GP.

Instead of an outpatient consultation, a healthcare provider can do the consultation remotely. A first outpatient visit, which is carried out by telephone or in writing, may temporarily be registered as a regular first outpatient visit. It is already permitted to register a screen-to-screen consultation as the first consultation.

Reimbursement for home care technologies has been broadened and simplified since 2020. In 2019, the care provider can claim a maximum of 4 hours of screen communication and a maximum of 2.5 hours of remote pharmaceutical care per patient per month at the agreed hourly tariff for nursing and personal care services. Since 2020, for a patient who receives the home care technology, a maximum of 6.5 hours per month can be declared at a maximum agreed tariff for nursing and / or personal care. Direct contact time required with home care technology can be declared through regular services. This extra compensation is possible in addition to the hours for direct contact time in the case of video calling with a patient.

In 2020, speech therapy will have a specific temporary performance for digital care called telelogopedy, when it is permitted to physically see a patient at least once at the beginning of a treatment course. Since 2021, this performance will expire, and there will be no restrictions for declaring digital care for speech therapy.

The full details in Dutch can be found here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news


Oct 2021

The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency providing advice to NHSScotland on the use of new and existing health technologies, likely to have a significant impact on healthcare. In the third quarter of 2021, SHTG published only one report in relation to HeartFlow fractional flow reserve computerized tomography (FFRCT). Currently, the SHTG is working on assessments of technologies in the field of diabetes, digital health, surgical procedures, and other topics.

Read more


Oct 2021

On September 20, 2021, Swedish Medical Technologies Product (MTP) Council announced ongoing horizon scanning for medical technology products used in obstructive lung diseases within the Orderly introduction framework. The Dental and Pharmaceutical Benefits Agency (TLV) initiated a theme survey, accepting suggestions until October 15, 2021.

Read more


Oct 2021

In September 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis, transapical transcatheter mitral valve-in-ring (TMVIR) after failed annuloplasty for mitral valve repair, and lateral elbow resurfacing for arthritis), and two new Medtech Innovation Briefings (Carnation Ambulatory Monitor, OrganOx metra for liver transplant). Also, one clinical guideline was updated.

Read more


Oct 2021

On September 10, 2021, it was announced that the Government of Spain had increased the budget allocated to the Spanish Network of Agencies for the Evaluation of Health Technologies and Benefits (RedETS) by 48.2% (compared to last year) for the development of the annual work plan. In total, the 2021 budget for the evaluation of health technologies in the National Health System amounts to €6,149,510. As a consequence of the budget increase, the RedETS 2021 Work Plan has included three new lines of evaluation.

Read more


Oct 2021

On August 26, 2021, the Dutch Healthcare Authority (NZa) published the fourth release of the DRG package for the year 2021 (RZ21d).

Read more